tiprankstipranks
Trending News
More News >
Reviva Pharmaceuticals Holdings (RVPH)
NASDAQ:RVPH
US Market

Reviva Pharmaceuticals Holdings (RVPH) Income Statement

Compare
1,034 Followers

Reviva Pharmaceuticals Holdings Income Statement

Last quarter (Q3 2025), Reviva Pharmaceuticals Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Reviva Pharmaceuticals Holdings's net income was $-4.01M. See Reviva Pharmaceuticals Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -724.74K
Operating Expenses
$ 30.80M$ 39.50M$ 24.31M$ 10.10M$ 2.43M
Depreciation and Amortization
$ 30.80M$ 39.50M$ 194.71K$ 591.00$ 105.77K
EBITDA
$ -29.88M$ -39.21M$ -24.11M$ -10.10M$ -2.33M
Operating Income
$ -30.80M$ -39.50M$ -24.31M$ -10.10M$ -2.43M
Other Income/Expenses
$ 899.60K$ 259.75K$ -11.91K$ 1.59M$ -1.35M
Pretax Income
$ -29.90M$ -39.24M$ -24.32M$ -8.52M$ -3.78M
Net Income
$ -29.92M$ -39.26M$ -24.34M$ -8.52M$ -3.78M
Per Share Metrics
Basic EPS
$ -0.90$ -1.65$ -1.45$ -0.58$ -1.24
Diluted EPS
$ -0.90$ -1.65$ -1.45$ -0.58$ -1.24
Weighted Average Shares Outstanding
33.15M 23.80M 19.52M 14.79M 3.06M
Weighted Average Shares Outstanding (Diluted)
33.15M 23.80M 19.52M 14.79M 3.06M
Currency in USD

Reviva Pharmaceuticals Holdings Earnings and Revenue History